Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
暂无分享，去创建一个
C. Ng | J. Heymach | A. Sood | E. Jackson | R. Iyer | R. Coleman | P. Ramirez | S. Modesitt | L. Duska | A. Kamat | V. Kundra | R. Jaffe | K. Schmeler | Aparna A. Kamat | Michael E Garcia | Debbie L Miller | J. Heymach | D. Miller | Debbie L Miller | Debbie L Miller | Debbie L Miller